Wei Xue,
Research Assistant Professor
About Wei Xue
Dr. Wei Xue is a Research Assistant Professor with the biostatistics department with a shared research assignment. She is a valuable member of the Children’s Oncology Group (COG), the world’s largest NIH/NCI sponsored clinical trials organization devoted exclusively to childhood and adolescent cancer research. Dr. Xue is the lead statistician on Soft Tissue Sarcoma (STS) Committees. She provides statistical support in all aspects of COG clinical trials in STS area by developing protocols, monitoring ongoing trials, conducting statistical analysis, and reporting and uploading research documents. Additionally, she is a member of the Biostatistics, Epidemiology and Research Design (BERD) group. A team of researchers who provide a central location for investigators to seek research design and analysis support through the UF Clinical and Translational science Institute (CTSI).
Teaching Profile
Courses Taught
2023-2025
PHC6790 Biostatistical Methods Using SAS
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0003-2680-8510
Publications
Academic Articles
2024
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children’s Oncology Group.
The Lancet. Oncology.
25(7):912-921
[DOI] 10.1016/S1470-2045(24)00255-9.
[PMID] 38936378.
2024
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Pediatric blood & cancer.
71(4)
[DOI] 10.1002/pbc.30847.
[PMID] 38282125.
2024
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children’s Oncology Group study ARST0332.
Cancer.
130(15):2683-2693
[DOI] 10.1002/cncr.35305.
[PMID] 38567652.
2024
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children’s Oncology Group.
Pediatric blood & cancer.
71(7)
[DOI] 10.1002/pbc.31009.
[PMID] 38627882.
2024
Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children’s Oncology Group.
Cancer.
130(14):2493-2502
[DOI] 10.1002/cncr.35276.
[PMID] 38470405.
2024
Respiratory Strength Training versus Respiratory Relaxation Training in the Rehabilitation of Physical Impairment, Function and Return to Participation Post-Stroke: Protocol for a Randomized Controlled Trial (Preprint)
JMIR Research Protocols.
13
[DOI] 10.2196/59749.
[PMID] 39602207.
2023
Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate-risk rhabdomyosarcoma: A report from Children’s Oncology Group.
Pediatric blood & cancer.
[DOI] 10.1002/pbc.30436.
[PMID] 37243336.
2023
Home Monitoring for Fever: An Inexpensive Screening Method to Prevent Household Spread of COVID-19.
Journal of biotechnology and biomedicine.
6(3):392-400
[DOI] 10.26502/jbb.2642-91280101.
[PMID] 38745997.
2023
Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children’s Oncology Group.
Cancer medicine.
12(11):12777-12791
[DOI] 10.1002/cam4.5921.
[PMID] 37081771.
2023
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee.
Pediatric blood & cancer.
70(7)
[DOI] 10.1002/pbc.30357.
[PMID] 37070563.
2023
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children’s Oncology Group and NRG Oncology.
Journal of surgical oncology.
127(5):871-881
[DOI] 10.1002/jso.27205.
[PMID] 36779385.
2023
Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children’s Oncology Group studies.
Pediatric blood & cancer.
70(12)
[DOI] 10.1002/pbc.30701.
[PMID] 37783659.
2023
Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Pediatric blood & cancer.
70(6)
[DOI] 10.1002/pbc.30293.
[PMID] 36916768.
2023
Survival after Pure (Acute) Erythroid Leukemia in the United States: A SEER-Based Study.
Cancers.
15(15)
[DOI] 10.3390/cancers15153941.
[PMID] 37568757.
2023
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children’s Oncology Group studies from 1997 to 2013: A report from the Children’s Oncology Group.
Cancer.
129(11):1735-1743
[DOI] 10.1002/cncr.34723.
[PMID] 36857314.
2022
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children’s Oncology Group clinical trials.
Pediatric blood & cancer.
69(4)
[DOI] 10.1002/pbc.29511.
[PMID] 35129294.
2022
Cancer patients’ satisfaction with telehealth during the COVID-19 pandemic.
PloS one.
17(6)
[DOI] 10.1371/journal.pone.0268913.
[PMID] 35657778.
2022
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children’s Oncology Group.
Pediatric blood & cancer.
69(6)
[DOI] 10.1002/pbc.29644.
[PMID] 35253352.
2022
Closed-Loop, Cervical, Epidural Stimulation Elicits Respiratory Neuroplasticity after Spinal Cord Injury in Freely Behaving Rats.
eNeuro.
9(1)
[DOI] 10.1523/ENEURO.0426-21.2021.
[PMID] 35058311.
2022
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).
Pediatric blood & cancer.
69(11)
[DOI] 10.1002/pbc.29924.
[PMID] 35969120.
2022
Dental diseases are associated with increased odds ratio for coronavirus disease 19.
Oral diseases.
28 Suppl 1(Suppl 1):991-993
[DOI] 10.1111/odi.13653.
[PMID] 32989904.
2022
Evaluation of glycemic control in critically ill patients with bacteremia: a retrospective, single-center cohort study.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
70(6):1387-1391
[DOI] 10.1136/jim-2021-002229.
[PMID] 35580916.
2022
Herpes simplex and herpes zoster viruses in COVID-19 patients.
Irish journal of medical science.
191(3):1093-1097
[DOI] 10.1007/s11845-021-02714-z.
[PMID] 34247308.
2022
Impact of ACA implementation on health related quality of life among those with depressive disorders in the United States: A secondary data analysis of the 2011-2017 BRFSS.
PloS one.
17(3)
[DOI] 10.1371/journal.pone.0266402.
[PMID] 35358271.
2022
Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
Cancer.
128(23):4150-4156
[DOI] 10.1002/cncr.34497.
[PMID] 36250420.
2021
Correlation of central corneal thickness and associated factors in premature infants with and without retinopathy of prematurity.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
56(3):171-178
[DOI] 10.1016/j.jcjo.2020.09.006.
[PMID] 33011153.
2021
Increased risk for COVID-19 in patients with vitamin D deficiency.
Nutrition (Burbank, Los Angeles County, Calif.).
84
[DOI] 10.1016/j.nut.2020.111106.
[PMID] 33418230.
2021
Sarcoidosis among US Hispanics in a Nationwide Registry.
Respiratory medicine.
190
[DOI] 10.1016/j.rmed.2021.106682.
[PMID] 34788736.
2020
‘Time to first tobacco cigarette soon after waking’ occurs more often among underage newly incident smokers in the United States, 2004-2017.
Addictive behaviors.
111
[DOI] 10.1016/j.addbeh.2020.106535.
[PMID] 32712495.
2020
Diabetes Mellitus and Periapical Abscess: A Cross-sectional Study.
Journal of endodontics.
46(11):1605-1609
[DOI] 10.1016/j.joen.2020.08.015.
[PMID] 32827508.
2020
Promoting Clinical Conversations about Lung Cancer Screening: Exploring the Role of Perceived Online Social Support.
Journal of health communication.
25(8):650-659
[DOI] 10.1080/10810730.2020.1836087.
[PMID] 33119451.
2020
Pulmonary hypertension in patients with interstitial pneumonia with autoimmune features.
Pulmonary circulation.
10(4)
[DOI] 10.1177/2045894020944117.
[PMID] 33343878.
2018
Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold.
Physical chemistry chemical physics : PCCP.
20(46):29513-29527
[DOI] 10.1039/c8cp06232c.
[PMID] 30457616.
2013
Discovery and antitumor activities of constituents from Cyrtomium fortumei (J.) Smith rhizomes.
Chemistry Central journal.
7(1)
[DOI] 10.1186/1752-153X-7-24.
[PMID] 23379693.
2013
RIRS versus mPCNL for single renal stone of 2-3Â cm: clinical outcome and cost-effective analysis in Chinese medical setting.
Urolithiasis.
41(1):73-8
[DOI] 10.1007/s00240-012-0533-8.
[PMID] 23532427.
2012
Design, synthesis and biological evaluation of novel betulinic acid derivatives.
Chemistry Central journal.
6(1)
[DOI] 10.1186/1752-153X-6-141.
[PMID] 23174002.
Presentations
2023-06-05
Risk stratification analysis for childhood rhabdomyosarcoma with international clinical trial data
International
/
Refereed.
Lecture.
2023-12-07
Risk stratification analysis for childhood rhabdomyosarcoma with international clinical trial data
International
/
Other.
Speech.
2024-06-04
Comparison of the Survival tree to Cox Regression in Predicting the Event free survival of rhabdomyosarcoma patients
International
/
Other.
Speech.
Grants
Mar 2023
ACTIVE
Children's Oncology Group Statistics and Data Center
Role: Project Manager
Funding: UNIV OF SOUTHERN CALIFORNIA
via NATL INST OF HLTH NCI
Jun 2022
– Aug 2023
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Jul 2021
– Feb 2022
Statistical Support for INSTRUCT Project with ECU
Role: Principal Investigator
Funding: EAST CAROLINA UNIV
Jun 2020
– Nov 2022
Statistical and data support for the International Soft Tissue sarcoma Consortium (INSTRuCT)
Role: Principal Investigator
Funding: SEATTLE CHILDRENS HOSPITAL
Jul 2019
– Jun 2022
Pediatric Cancer Data Commons
Role: Principal Investigator
Funding: UNIV OF CHICAGO
via ST BALDRICKS FOUNDATION
Apr 2019
– Feb 2023
Children's Oncology Group Statistics and Data Center
Role: Project Manager
Funding: PUBLIC HLTH INST
via NATL INST OF HLTH NCI
Education
PhD
2016
·
Michigan State University
MS
2003
·
University of Florida
BS
2000
·
Nankai University
Contact Details
Phones:
- Business:
- (352) 273-0557
Emails:
- Business:
- qiangxue@ufl.edu
Addresses:
- Business Mailing:
-
2004 MOWRY RD
GAINESVILLE FL 32611 - Business Street:
-
PO BOX 117450
GAINESVILLE FL 326100001